La settimana scorsa, l’Agenzia europea per il farmaco (EMA) è riuscita a convincere Big Pharma che la segretezza generava sfiducia: The first phase starts on 1 January 2015. Once a medicine has received a marketing authorisation, EMA will publish the clinical reports supporting applications for authorisation of medicines submitted after the policy’s entry into force. For… Continua a leggere Trasparenza